Thursday, May 5, 2011

Celgenes Revlimid extends life in cancer trial

Celgene Corp's cancer drug, Revlimid, significantly extended the lives of patients with multiple myeloma who took the drug as a maintenance therapy following a stem cell transplant.

Data presented at the 2011 International Myeloma Workshop in Paris showed patients who took the drug for an extended period had a slightly greater risk of developing a second primary malignancy (SPM) -- something that pushed the company's shares down 3.1 percent -- but analysts said the overall benefit of the drug exceeds the risk.

Revlimid is already approved to treat multiple myeloma in patients who have failed at least one previous treatment. The company is seeking to show that patients can benefit if they receive treatment earlier and for longer periods.

Monday, May 2, 2011

Hollywood Actors and Actresses Suffering Hair Loss

Hollywood is notorious for its mellow standards for dear looks and good health. With the Academy Awards happening this February, actors and actresses are look for ways to fulfill their herd of admirers. From designer gowns and glittering jewels to mellow heeled stilettos and gorgeous hairsbreadth styles, celebrities are in rival for the hottest look and the contact poses.

Good looks are important in the reality of amusement, yet hardly wish the relaxation of us, celebrities have fuzz release. Celebrity fuzz loss is becoming an progressively hot issue in the media. Fans and paparazzi like espouse their favorite and near talked around stars and hold up with the tabloids and latest chitchat on them.